Categories: News

BioDelivery Sciences to Report First Quarter 2021 Financial Results on May 6, 2021

RALEIGH, N.C., April 20, 2021 (GLOBE NEWSWIRE) — BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its first quarter 2021 financial results before the open of the U.S. financial markets on Thursday, May 6, 2021. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.

Conference Call Dial-In & Webcast Information:

  Date:  Thursday, May 6, 2021
  Time: 8:30 AM Eastern Time
  Domestic: 877-407-0789
  International: 201-689-8562
  Conference ID: 13718097
  Webcast: http://public.viavid.com/index.php?id=144116

About BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI’s marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

© 2021 BioDelivery Sciences International, Inc.  All rights reserved.

Contact:
Bob Yedid
LifeSci Advisors
646-597-6989
Bob@LifeSciAdvisors.com

 

Staff

Recent Posts

ECP Completes Massive Growth Financing to Accelerate Investment in AI Platform for Assisted Living

MILWAUKEE--(BUSINESS WIRE)--#assistedliving--ECP, the leading software platform purpose-built for assisted living, announced today a significant growth…

29 minutes ago

Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process

Believes Belated Go-Shop Process Fails to Cure Fundamental Flaws in the Transaction’s Process, Timing, and…

30 minutes ago

Welldoc Partners with CLEAR to Integrate Secure Identity Verification in AI-Powered Cardiometabolic Health Platform

Collaboration Advances CMS Health Tech Ecosystem Goals by Enabling Seamless, Secure Access to Health Data…

3 hours ago

Both Ends Believing Celebrates 15 Years of Transforming Global Child Welfare Through Technology

DALLAS, Dec. 4, 2025 /PRNewswire/ -- Both Ends Believing (BEB), a Dallas-based global nonprofit with…

4 hours ago

Sage introduces skilled nursing solution to Sage Core, expanding its unified platform across all levels of senior care

Skilled brings wireless-first nurse call, real-time insights, and integrated workflows, completing Sage Core's support across…

4 hours ago

MJFF Initiates Funding for Emerging Therapeutic Targets in Parkinson’s Disease

NEW YORK, Dec. 8, 2025 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF)…

4 hours ago